<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00351793</url>
  </required_header>
  <id_info>
    <org_study_id>CDHA-RL-004</org_study_id>
    <nct_id>NCT00351793</nct_id>
  </id_info>
  <brief_title>A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement</brief_title>
  <official_title>A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ross Leighton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nova Scotia Health Authority</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to look at the outcomes of the GENESIS II Posterior Stabilized
      Total Knee Replacement.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness and Safety</measure>
    <time_frame>5 years</time_frame>
    <description>Will evaluate effectiveness and safety during a 5 year period via analysis of the Knee Society Score, revision status, and radiographic evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Society Clinical Rating</measure>
    <time_frame>Pre-op, 6 months, 1 year, 2 years, 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>Pre-op, 6 months, 1 year, 2 years, 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">186</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Combined Deformity &lt;30 degrees</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Deformity &gt;30 degrees</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knee Implant</intervention_name>
    <description>Total knee replacement with Genesis II posterior stabilized knee</description>
    <arm_group_label>Combined Deformity &lt;30 degrees</arm_group_label>
    <arm_group_label>Combined Deformity &gt;30 degrees</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Total knee replacement candidates
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A combined deformity of &lt;30 degrees = group 1

          -  A combined deformity of &gt;30 degrees = group 2

          -  Patient is willing to consent to participate in the study

          -  Patient is available for follow-up through at least 2 years but preferably 5 years

          -  Patient has met acceptable preoperative medical clearance and is free of or treated
             for medical conditions that would pose excessive operative risk

          -  Patients who are fluent in English and are able to understand their role in a clinical
             trial

        Exclusion Criteria:

          -  Active, local infection or systemic infection

          -  Fibromyalgia patients

          -  Patients whom, as judged by the surgeon, are not capable of understanding the informed
             consent or the requirements of the protocol and or are reasonably unlikely to be
             compliant with the prescribed routine and the follow-up evaluation schedule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ross K Leighton, MD, FRCS(C)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Health, Canada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>QEII Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2006</study_first_submitted>
  <study_first_submitted_qc>July 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2006</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Ross Leighton</investigator_full_name>
    <investigator_title>Orthopedic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

